Inflammation is a key condition in the development/progression of MASLD, which is characterized by an increased production of proinflammatory cytokines within the liver or by other tissues and reduced anti-inflammatory factors like adiponectin [55]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.